ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
308 Phase I of axitinib and everolimus in metastatic solid tumors and extension to metastatic renal cell carcinoma (mrcc): Results of EVAX study
European Journal of Cancer
◽
10.1016/s0959-8049(16)30173-3
◽
2015
◽
Vol 51
◽
pp. S57
Author(s):
A. Ravaud
◽
C. Gomez-roca
◽
M.Q. Picat
◽
L. Digue
◽
C. Chevreau
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Solid Tumors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
Download Full-text
Related Documents
Cited By
References
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Annals of Oncology
◽
10.1093/annonc/mdw188
◽
2016
◽
Vol 27
(8)
◽
pp. 1579-1585
◽
Cited By ~ 19
Author(s):
S.M. Keefe
◽
J. Hoffman-Censits
◽
R.B. Cohen
◽
R. Mamtani
◽
D. Heitjan
◽
...
Keyword(s):
Clinical Trial
◽
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Drug Conjugate
Download Full-text
A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma
Journal of Immunotherapy
◽
10.1097/cji.0000000000000023
◽
2014
◽
Vol 37
(3)
◽
pp. 180-186
◽
Cited By ~ 8
Author(s):
Paul Monk
◽
Elaine Lam
◽
Amir Mortazavi
◽
Kari Kendra
◽
Gregory B. Lesinski
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
◽
Interleukin 2
◽
High Dose
Download Full-text
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
European Journal of Cancer
◽
10.1016/j.ejca.2017.07.031
◽
2017
◽
Vol 85
◽
pp. 39-48
◽
Cited By ~ 1
Author(s):
Alain Ravaud
◽
Carlos Gomez-Roca
◽
Marie-Quitterie Picat
◽
Laurence Digue
◽
Christine Chevreau
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
◽
Solid Tumours
Download Full-text
Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc)
Annals of Oncology
◽
10.1093/annonc/mdu342.3
◽
2014
◽
Vol 25
◽
pp. iv361
◽
Cited By ~ 13
Author(s):
H. Hammers
◽
E.R. Plimack
◽
J.R. Infante
◽
M. Ernstoff
◽
B.I. Rini
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
Download Full-text
A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a059358
◽
1995
◽
Vol 6
(9)
◽
pp. 911-914
◽
Cited By ~ 11
Author(s):
R. Amato
◽
C. Meyers
◽
J. Ellerhorst
◽
L. Finn
◽
R. Kilbourn
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Trial
◽
High Dose
Download Full-text
Abstract CT217: An open-label, Phase I/IIa study of VB10.NEO (DIRECT-01) in combination with checkpoint blockade in patients with locally advanced or metastatic solid tumors including melanoma, NSCLC, renal cell carcinoma, urothelial cancer or SSCHN
10.1158/1538-7445.sabcs18-ct217
◽
2019
◽
Author(s):
Jurgen Krauss
◽
Angela Krackhardt
◽
Elke Jager
◽
Anja Williams
◽
Hedda Wold
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Solid Tumors
◽
Renal Cell
◽
Urothelial Cancer
◽
Locally Advanced
◽
Checkpoint Blockade
◽
Open Label
◽
Open Label Phase
Download Full-text
A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
The Oncologist
◽
10.1634/theoncologist.2019-0599
◽
2019
◽
Vol 25
(2)
◽
pp. 121
◽
Cited By ~ 4
Author(s):
Andrew W. Hahn
◽
Charles Drake
◽
Samuel R. Denmeade
◽
Yousef Zakharia
◽
Benjamin L. Maughan
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Study
Download Full-text
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
Cancer Immunology Immunotherapy
◽
10.1007/s00262-018-2288-8
◽
2019
◽
Vol 68
(3)
◽
pp. 503-515
◽
Cited By ~ 9
Author(s):
Charlotte M. Huijts
◽
◽
Sinéad M. Lougheed
◽
Zuhir Bodalal
◽
Carla M. van Herpen
◽
...
Keyword(s):
Clinical Trial
◽
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Immune Cell
◽
Phase I Clinical Trial
◽
Immune Cell Subsets
Download Full-text
A Phase I/II Trial of Bnc105P with Everolimus in Metastatic Renal Cell Carcinoma (Mrcc): Results of the Randomized Phase Ii Disruptor-1 Trial
Annals of Oncology
◽
10.1093/annonc/mdu337.8
◽
2014
◽
Vol 25
◽
pp. iv283
Author(s):
S. Pal
◽
A. Azad
◽
S. Bhatia
◽
H. Drabkin
◽
B. Costello
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Randomized Phase Ii
Download Full-text
Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
◽
10.3816/cgc.2009.n.005
◽
2009
◽
Vol 7
(1)
◽
pp. 28-33
◽
Cited By ~ 52
Author(s):
Robert J. Motzer
◽
Gary Hudes
◽
George Wilding
◽
Lawrence H. Schwartz
◽
Subramanian Hariharan
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase I Trial
◽
Interferon Α
◽
Sunitinib Malate
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close